Profil
Doug Hubatsch is currently the Chief Scientific Officer at Nicox SA since 2021.
Prior to this, he worked at Novartis Pharmaceuticals as the Global Head-Ocular Surface Diseases.
Postes actifs de Doug Hubatsch
| Sociétés | Poste | Début |
|---|---|---|
| NICOX SA | Chief Tech/Sci/R&D Officer | 13/12/2021 |
Anciens postes connus de Doug Hubatsch
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NICOX SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Health Technology |
